Skip to main navigation
  • Menu
  • Investors

  • Investors
  • Press Releases

  • Press Releases
  • Events and Presentations

  • Events & Presentations
  • Corporate Governanace

  • Corporate Governance
    Other Related Links
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials and Filings

  • Financials & Filings
    Other Related Links
    • SEC Filings
    • Annuals and Proxies
    • Quarterly Results
  • Stock Information

  • Stock Information
    Other Related Links
    • Historic Stock Lookup
    • Investment Calculator
    • Ownership Profile
  • Investor FAQ's

  • Investor FAQ's
  • Contact Us

  • Contact Us
    • A Legacy of Innovation, a portfolio of promise™

      © 2020 Supernus Pharmaceuticals, Inc.

    • Sitemap
    • Terms of Use
    • Privacy Policy

Breadcrumb

Investor Relations
Corporate governance
Committee Composition

Committee Composition

Back to Investors

Corporate Governanace

Corporate Governance
Management
Board of Directors
Committee Composition
Contact the Board

Committee Composition

Independent Director Audit Governance and Nominating Compensation
Charles W. Newhall III Independent Director Governance and Nominating Compensation
Georges Gemayel PhD Independent Director Audit Governance and Nominating
Frederick M. Hudson Independent Director Audit Compensation
Jack A. Khattar
John M. Siebert PhD Independent Director Audit Compensation
= Independent Director = Chairperson = Member = Chairman of the Board

Shareholder Tools

  • Print
  • Email Alerts
  • Downloads
  • RSS Feeds
  • Search
© 2020 Supernus Pharmaceuticals, Inc.